Please login to the form below

Not currently logged in
Email:
Password:

Germans test drug authentication system

An authentication system for pharmacists to check medicinal packs before dispensing is being trialled in Germany

An authentication system for pharmacists to check medicinal packs before dispensing is being trialled in Germany. 

The Federal Union of German Associations of Pharmacists (ABDA) will evaluate the impact and benefits of the Aegate system, which already operates in Belgium, Greece and Italy.  

The programme was also shown to, and discussed with, the Bundesverband der Pharmazeutischen Industrie (German Pharmaceutical Association, BPI). 

The service enables the pharmacist to check that packs are in date, not recalled or potentially counterfeit and also provides the latest drug safety information. 

Aegate's system was adapted to work alongside Germany's current reimbursement framework and enables evaluation of 2D data-matrix serialisation technology.  

The trial will last around seven months and includes pharmacies, pharmaceutical manufacturers and wholesalers. 

Many European member states will be installing authentication systems in line with the European Commission's forthcoming directive on counterfeit medicines, which seeks mandatory safety features to identify, authenticate and trace all medicine packs, and is set to happen in 2010.

10th February 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics